Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous data streams, according to some industry experts.

Medtronic plc (NYSE: MDT) today announced financial results for its second quarter (Q2) of fiscal year 2025 (FY25), which ended October 25, 2024.

This free printable All About Me worksheet is a unique and exciting project for your little ones of any age. Print these ...

About 140 million Americans, more than half of the nation's adults, could be considered candidates for weight loss drugs ...

Delivering on commitments, executing ahead of expectations, and raising guidanceInnovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine ...

The Federal Emergency Management Agency and Department of Agriculture would receive the bulk of the funding request for ...